Ondine Biopharma Corporation

Details Ondine Biopharma Corporation Ondine Biopharma Corporation

www.ondinebiopharma.com

British Columbia

Vancouver

Vancouver

Corporation

active

Ondine Biopharma Inc. (Ondine) is a preclinical stage pharmaceutical company engaged in the development and commercialization of novel therapies for oral infectious disease.
Ondine is currently involved in the development of a proprietary technology for treating infections using light-activated drugs.
Ondine is currently in preclinical development of the PACT technology and anticipates entering human clinical trials in both the UK and the United States during 2001. Based on the current development plans, a PACT product for treating periodontal disease could be on the market within the next four to five years.
During the commercial development and regulatory approval of PACT for periodontal disease, Ondine intends to expand its product portfolio to include other medical applications of PACT, as well as acquiring new platform technologies for the treatment of infectious disease.
Country of Ownership: Canada
Year Established: 1998
Exporting: No
Primary Industry (NAICS): 414510 - Pharmaceuticals and Pharmacy Supplies Wholesaler-Distributors
Primary Business Activity: Manufacturer / Processor / Producer
Number of Employees: 5

Products:
Pharmaceuticals

Affiliated with

Also associated with

No associations

Rating

Ondine Biopharma Corporation does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with Ondine Biopharma Corporation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ondine Biopharma Corporation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-COD-O-32006